[Prevalence and risk factors of delirium in COVID-19].

Yu G Tikhonova, M A Kinkulkina, A V Volkov, V A Sedelkova, T I Avdeeva, T A Izyumina, M A Makarova, T N Maximova, M Yu Brovko, S V Moiseev, N N Ivanets
{"title":"[Prevalence and risk factors of delirium in COVID-19].","authors":"Yu G Tikhonova,&nbsp;M A Kinkulkina,&nbsp;A V Volkov,&nbsp;V A Sedelkova,&nbsp;T I Avdeeva,&nbsp;T A Izyumina,&nbsp;M A Makarova,&nbsp;T N Maximova,&nbsp;M Yu Brovko,&nbsp;S V Moiseev,&nbsp;N N Ivanets","doi":"10.17116/jnevro202312307186","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess the frequency and risk factors of delirium in patients hospitalized with COVID-19.</p><p><strong>Material and methods: </strong>Four hundred and forty patients admitted to the Infectious Diseases Hospital of the University Clinical Hospital No.3 of Sechenov University were included in the study. The Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Screening Questionnaire-7 (GAD-7), the Insomnia Severity Index (ISI), the Delirium severity rating scale (DRS-R-98) were administered.</p><p><strong>Results: </strong>Delirium was detected in 27.8% of patients. Significant risk factors were age (<i>p</i>=0.002), severity of respiratory failure (<i>p</i>=0.005), concomitant somatic disease (<i>p</i>=0.003), and respiratory therapy (<i>p</i><0.001). There was an association between severe anxiety (<i>p</i><0.001) and insomnia (<i>p</i>=0.07) observed at admission with the risk of developing delirium during the hospital stay.</p><p><strong>Conclusion: </strong>The study reveals a high prevalence of delirium in patients with COVID-19. In order to prevent delirium and/or reduce the risk, early diagnosis and identification of preclinical forms are of particular importance.</p>","PeriodicalId":24030,"journal":{"name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/jnevro202312307186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To assess the frequency and risk factors of delirium in patients hospitalized with COVID-19.

Material and methods: Four hundred and forty patients admitted to the Infectious Diseases Hospital of the University Clinical Hospital No.3 of Sechenov University were included in the study. The Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Screening Questionnaire-7 (GAD-7), the Insomnia Severity Index (ISI), the Delirium severity rating scale (DRS-R-98) were administered.

Results: Delirium was detected in 27.8% of patients. Significant risk factors were age (p=0.002), severity of respiratory failure (p=0.005), concomitant somatic disease (p=0.003), and respiratory therapy (p<0.001). There was an association between severe anxiety (p<0.001) and insomnia (p=0.07) observed at admission with the risk of developing delirium during the hospital stay.

Conclusion: The study reveals a high prevalence of delirium in patients with COVID-19. In order to prevent delirium and/or reduce the risk, early diagnosis and identification of preclinical forms are of particular importance.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[COVID-19患者谵妄的患病率及危险因素]。
目的:了解新型冠状病毒肺炎住院患者谵妄发生频率及危险因素。材料与方法:选取谢切诺夫大学第三大学临床医院感染性医院住院的440例患者为研究对象。采用患者健康问卷(PHQ-9)、广泛性焦虑障碍筛查问卷-7 (GAD-7)、失眠严重程度指数(ISI)、谵妄严重程度评定量表(DRS-R-98)。结果:谵妄发生率为27.8%。入院时观察到年龄(p=0.002)、呼吸衰竭严重程度(p=0.005)、伴发躯体疾病(p=0.003)和呼吸治疗(ppp=0.07)为住院期间发生谵妄的危险因素。结论:新冠肺炎患者谵妄发生率高。为了预防谵妄和/或降低风险,早期诊断和临床前形式的识别是特别重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Medicine-Psychiatry and Mental Health
CiteScore
0.80
自引率
0.00%
发文量
0
期刊最新文献
[The impact of depression symptoms on postmorbid adaptation of patients who have undergone SARS-CoV-2 infection (assessment from the position of the multimorbidity model)]. [Differential diagnosis of immune reconstitution inflammatory syndrome and progressive multifocal leukoencephalopathy after natalizumab withdrawal]. [The use of a fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndrome in patients with discogenic lumbosacral radiculopathy and lumboischialgia]. [Coherence of the electroencephalogram and peripheral markers of nerve tissue damage in depressive disorders]. [Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1